{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:23:01Z","timestamp":1794633781255,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.trre.2026.101060","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:30:40Z","timestamp":1791613840000},"page":"101060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Living donor liver transplantation in transplant oncology: A disease-specific framework for access, timing, and donor risk"],"prefix":"10.1016","volume":"40","author":[{"given":"Dimitrios","family":"Moris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A.","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Theocharopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Walls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Gogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri S.","family":"Genyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2026.101060_bb0005","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/j.1600-6143.2007.01802.x","article-title":"Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation","volume":"7","author":"Fisher","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0010","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1111\/j.1600-6143.2012.04272.x","article-title":"Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort","volume":"12","author":"Kulik","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hpb.2018.11.004","article-title":"Living or deceased organ donors in liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"21","author":"Zhu","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.trre.2026.101060_bb0020","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/CM9.0000000000000287","article-title":"Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic review and meta-analysis","volume":"132","author":"Zhang","year":"2019","journal-title":"Chin Med J"},{"key":"10.1016\/j.trre.2026.101060_bb0025","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/lt.26439","article-title":"National experience with living donor liver transplantation for hepatocellular carcinoma","volume":"28","author":"Silverstein","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2026.101060_bb0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2018.12.029","article-title":"Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation","volume":"70","author":"Goldaracena","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2026.101060_bb0035","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/tri.13391","article-title":"Japanese liver transplantation society. Expanded living-donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5-5-500 rule\u2014a retrospective study","volume":"32","author":"Shimamura","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101060_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jamcollsurg.2019.12.037","article-title":"Living donor liver transplantation for perihilar cholangiocarcinoma: outcomes and complications","volume":"231","author":"Tan","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jhbp.12121","article-title":"Safety and efficacy of living donor liver transplantation for unresectable perihilar cholangiocarcinoma: a single center prospective study","volume":"32","author":"Ito","year":"2025","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.trre.2026.101060_bb0050","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/curroncol29030157","article-title":"Living donor liver transplantation for intrahepatic cholangiocarcinoma","volume":"29","author":"Rauchfu\u00df","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.trre.2026.101060_bb0055","doi-asserted-by":"crossref","DOI":"10.1590\/0102-6720202400045e1839","article-title":"Living donor liver transplant for intrahepatic cholangiocarcinoma. An initial Brazilian experience","volume":"37","author":"Fernandes","year":"2024","journal-title":"Arq Bras Cir Dig"},{"key":"10.1016\/j.trre.2026.101060_bb0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ajt.2024.10.023","article-title":"Neoadjuvant pemigatinib as a bridge to living donor liver transplantation for intrahepatic cholangiocarcinoma with FGFR2 gene rearrangement","volume":"25","author":"Byrne","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0065","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000545871","article-title":"Living donor liver transplantation for neoadjuvant-treated, unresectable intrahepatic cholangiocarcinoma (LIVINCA): study protocol for a one-armed, monocentric, non-randomized trial","volume":"48","author":"Schwenk","year":"2025","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.trre.2026.101060_bb0070","author":"Lerut"},{"key":"10.1016\/j.trre.2026.101060_bb0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.transproceed.2014.12.017","article-title":"Living donor liver transplantation: a life-saving option in emergency situations for diffuse hepatic neuroendocrine tumor metastasis","volume":"47","author":"Yankol","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2026.101060_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00535-024-02166-z","article-title":"Liver transplantation for gastroenteropancreatic neuroendocrine liver metastasis: optimal patient selection and perioperative management in the era of multimodal treatments","volume":"60","author":"Kasai","year":"2025","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.trre.2026.101060_bb0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamasurg.2022.0300","article-title":"Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases","volume":"157","author":"Hernandez-Alejandro","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/XCS.0000000000000734","article-title":"Toronto management of initially unresectable liver metastasis from colorectal cancer in a living donor liver transplant program","volume":"237","author":"Rajendran","year":"2023","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0095","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ajt.2024.09.027","article-title":"The Rochester protocol for living donor liver transplantation of unresectable colorectal liver metastasis: a 5-year report on selection, approval, and outcomes","volume":"25","author":"Byrne","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-088188","article-title":"Living-donor liver transplantation for non-resectable colorectal liver metastases: protocol for a multicentric, single-arm study","volume":"14","author":"Fukumitsu","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.trre.2026.101060_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12072-022-10435-3","article-title":"Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis","volume":"17","author":"Elkomos","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.trre.2026.101060_bb0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/SLA.0000000000006049","article-title":"Living donor liver transplantation for hepatocellular carcinoma within and outside traditional selection criteria: a multicentric north American experience","volume":"279","author":"Ivanics","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zrae079","article-title":"Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study","volume":"8","author":"Ohira","year":"2024","journal-title":"BJS Open"},{"key":"10.1016\/j.trre.2026.101060_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2025.14748","article-title":"Long-term prognostic value of AFP and PIVKA-II in hepatocellular carcinoma after living donor liver transplantation: a single-center retrospective study","volume":"38","author":"Gongor","year":"2025","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2026.101060_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000487","article-title":"Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER randomized clinical trial","volume":"31","author":"Pi\u00f1ero","year":"2025","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2026.101060_bb0120","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1007\/s00464-025-12011-w","article-title":"Long-term outcomes in deceased versus living donor liver transplantation for hepatocellular carcinoma: a bi-institutional study of 486 cases","volume":"39","author":"Di Benedetto","year":"2025","journal-title":"Surg Endosc"},{"key":"10.1016\/j.trre.2026.101060_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220527","article-title":"Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"14","author":"Moris","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2026.101060_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2019.100516","article-title":"Liver transplantation for hilar cholangiocarcinoma: a systematic review","volume":"34","author":"Machairas","year":"2020","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2026.101060_bb0215","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2026.101060_bb0200","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000589","article-title":"The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma","author":"Kodali","year":"2025","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2026.101060_bb0135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.surg.2017.05.006","article-title":"Liver transplantation in patients with liver metastases from neuroendocrine tumors: a systematic review","volume":"162","author":"Moris","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.trre.2026.101060_bb0140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jso.24671","article-title":"Liver transplantation for unresectable colorectal liver metastases: a systematic review","volume":"116","author":"Moris","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.trre.2026.101060_bb0230","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(24)01595-2","article-title":"Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial","volume":"404","author":"Adam","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2026.101060_bb0220","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182823957","article-title":"Liver transplantation for nonresectable liver metastases from colorectal cancer","volume":"257","author":"Hagness","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0225","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S2468-1253(21)00219-3","article-title":"Liver transplantation for non-resectable colorectal liver metastases: the international Hepato-Pancreato-biliary association consensus guidelines","volume":"6","author":"Bonney","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.trre.2026.101060_bb0235","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/SLA.0000000000006895","article-title":"Over 30 years of living liver donation in North America: mortality associated with donation","volume":"282","author":"King","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0240","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.gastro.2011.11.015","article-title":"Estimates of early death, acute liver failure, and long-term mortality among live liver donors","volume":"142","author":"Muzaale","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trre.2026.101060_bb0245","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1600-6143.2011.03972.x","article-title":"A2ALL study group. Complications of living donor hepatic lobectomy-a comprehensive report","volume":"12","author":"Abecassis","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0250","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1097\/TP.0000000000004213","article-title":"Right lobe versus left lobe living donor liver transplantation: a systematic review and meta-analysis of donor and recipient outcomes","volume":"106","author":"Acuna","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101060_bb0255","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1097\/TP.0000000000004214","article-title":"Right versus left: progress but no conclusion in selecting donors for live donor liver transplantation","volume":"106","author":"Emond","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101060_bb0275","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1600-6143.2012.04022.x","article-title":"Left lobe living donor liver transplantation in adults","volume":"12","author":"Soejima","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0260","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/SLA.0000000000001165","article-title":"A novel concept for partial liver transplantation in nonresectable colorectal liver metastases: the RAPID concept","volume":"262","author":"Line","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0265","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/SLA.0000000000002861","article-title":"Paradigm shift in the management of irresectable colorectal liver metastases: living donor auxiliary partial orthotopic liver transplantation in combination with two-stage hepatectomy (LD-RAPID)","volume":"270","author":"K\u00f6nigsrainer","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0270","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-018-1549-5","article-title":"Living donor liver transplantation with two-stage hepatectomy for patients with isolated, irresectable colorectal liver metastases\u2014the LIVER-T(W)O-HEAL study","volume":"17","author":"Rauchfu\u00df","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.trre.2026.101060_bb0280","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.3748\/wjg.v19.i48.9183","article-title":"Transplant benefit for patients with hepatocellular carcinoma","volume":"19","author":"Vitale","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trre.2026.101060_bb0285","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1002\/hep.29342","article-title":"European hepatocellular Cancer liver transplant study group. Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.trre.2026.101060_bb0295","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1002\/lt.22356","article-title":"Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations","volume":"17","author":"Pomfret","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2026.101060_bb0290","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jhep.2013.10.010","article-title":"A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list","volume":"60","author":"Vitale","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.trre.2026.101060_bb0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/ajt.16790","article-title":"Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and child-Pugh class a liver cirrhosis: a propensity score-matched comparison","volume":"22","author":"Yoon","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2026.101060_bb0150","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/jhbp.863","article-title":"Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: quantitative prediction using ADV score","volume":"28","author":"Hwang","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.trre.2026.101060_bb0155","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4174\/astr.2018.95.3.152","article-title":"Continuing five or more locoregional therapies before living donor salvage liver transplantation for hepatocellular carcinoma is related to poor recurrence-free survival","volume":"95","author":"Rhu","year":"2018","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.trre.2026.101060_bb0160","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/atm.2020.02.170","article-title":"Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection","volume":"8","author":"Kim","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.trre.2026.101060_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/lt.25956","article-title":"Incorporating tumor biology to predict hepatocellular carcinoma recurrence in patients undergoing living donor liver transplantation using expanded selection criteria","volume":"27","author":"Bhangui","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2026.101060_bb0170","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1097\/TP.0000000000003162","article-title":"Experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging","volume":"104","author":"Soin","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2026.101060_bb0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12664-020-01127-7","article-title":"Prognostic impact of incidentally detected hepatocellular carcinoma in explanted livers after living donor liver transplantation","volume":"40","author":"Rajakannu","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.trre.2026.101060_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18111687","article-title":"Oncologic outcomes after ABO-incompatible versus compatible living donor liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"18","author":"Kim","year":"2026","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.trre.2026.101060_bb0185","doi-asserted-by":"crossref","first-page":"11053","DOI":"10.1097\/JS9.0000000000004816","article-title":"ABO blood type has no effect on hepatocellular carcinoma recurrence after living donor liver transplantation in the Korean organ transplantation registry study: a case-control study","volume":"112","author":"Kim","year":"2026","journal-title":"Int J Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0190","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4240\/wjgs.v15.i7.1340","article-title":"Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: a multicenter study","volume":"15","author":"Kim","year":"2023","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.trre.2026.101060_bb0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/SLA.0b013e31828ee17c","article-title":"Liver transplantation for neuroendocrine tumors in Europe: results and trends in patient selection","volume":"257","author":"Le Treut","year":"2013","journal-title":"Ann Surg"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X26000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:42:56Z","timestamp":1794631376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X26000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0955470X26000704"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2026.101060","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Living donor liver transplantation in transplant oncology: A disease-specific framework for access, timing, and donor risk","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2026.101060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101060"}}